Unlocking AML Treatment: Duke Scientists Target Cancer Metabolism
Duke and Duke-NUS scientists use a novel computational approach to identify critical metabolic vulnerabilities in AML cells, paving the way for targeted, less toxic therapies. This breakthrough offers new hope for AML patients.